Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication

Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication

The aim of this study was to understand the effect of high shear homogenization (HSH) and ultrasonication (US) on the physicochemical properties of blank and olanzapine loaded nanostructured lipid carriers (NLCs) along with their drug loading potential and drug release profiles from formulated parti...

Full description

Bibliographic Details
Main Authors:	Adejumoke Lara Ajiboye, Uttom Nandi, Martin Galli, Vivek Trivedi
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Scientia Pharmaceutica
Subjects:	nanostructured lipid carriers ultrasonication high shear homogenization olanzapine
Online Access:	https://www.mdpi.com/2218-0532/89/2/25

Similar Items

Metacognitive Training Modulates Default-Mode Network Homogeneity During 8-Week Olanzapine Treatment in Patients With Schizophrenia
by: Xiaoxiao Shan, et al.
Published: (2020-03-01)

Production of Nanocellulose from Pineapple Leaf Fibers via High-Shear Homogenization and Ultrasonication
by: Melbi Mahardika, et al.
Published: (2018-05-01)

Teratogenicity with olanzapine
by: Sathya Prakash, et al.
Published: (2014-01-01)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
by: Pedro Cabral Barata, et al.
Published: (2019-07-01)

Enhancing the aqueous solubility and dissolution of olanzapine using freeze-drying
by: Mudit Dixit, et al.
Published: (2011-12-01)

Hematological safety of olanzapine
by: Asem A Alageel, et al.
Published: (2016-09-01)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
by: Huimei An, et al.
Published: (2022-06-01)

Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
by: Li J, et al.
Published: (2018-07-01)

Amisulpride and olanzapine in Capgras Syndrome
by: G Sanghamitra, et al.
Published: (2017-01-01)

Olanzapine-induced Psoriasis
by: Ashish Hanmantrao Chepure, et al.
Published: (2017-01-01)

Report of a Rare Case of Olanzapine and Risperidone Induced Hypomania
by: AR Zahiroddin, et al.
Published: (2006-07-01)

Anastrozole Loaded Nanostructured Lipid Carriers : Preparation and Evaluation
by: Alaa Abdul-Jabbar Hashim, et al.
Published: (2021-12-01)

Olanzapine-induced hiccups： a case report
by: Sun Zhenxiao, et al.
Published: (2021-04-01)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
by: S. Bise, et al.
Published: (2022-06-01)

Olanzapine induced hyponatremia and rhabdomyolysis
by: N'joumi Younes, et al.
Published: (2023-02-01)

Olanzapine induced tardive dyskinesia
by: Rudraprosad Chakraborty, et al.
Published: (2014-01-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
by: Ivy O. Poon, et al.
Published: (2024-02-01)

Cerrahi Müdahale Gerektiren Olanzapin İlişkili Paralitik İleus Olgusu
by: Halil İbrahim Taşçı
Published: (2019-03-01)

Rare occurence of amennorrhea associated with olanzapine : a case report
by: A. Khivsara, et al.
Published: (2022-06-01)

Thrombocytopenia associated with olanzapine: A case report and review of literature
by: Swapnajeet Sahoo, et al.
Published: (2016-01-01)

Emphysematous pancreatitis predisposed by Olanzapine
by: Sukhen Samanta, et al.
Published: (2014-01-01)

The incidence of dysrhythmias after administration of the antipsychotic olanzapine
by: Gulač P., et al.
Published: (2016-09-01)

Severe ischemic colitis following olanzapine use: a Case Report
by: Samuel Raimundo Fernandes, et al.

Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
by: Gustavo Henrique Rodrigues da Silva, et al.
Published: (2021-11-01)

Characterization and toxicity of citral incorporated with nanostructured lipid carrier
by: Noraini Nordin, et al.
Published: (2018-01-01)

Olanzapine-induced Priapism in a Child with Asperger’s Syndrome
by: Hasan Bozkurt, et al.
Published: (2017-02-01)

Is there association of olanzapine and pulmonary embolism: A case report
by: Lumin Wang, et al.
Published: (2022-06-01)

Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double-blind, multicentric trial
by: Sandip Shah, et al.
Published: (2011-01-01)

The effect and safety of olanzapine on nausea and vomiting in children receiving moderately emetogenic chemotherapy
by: Aziz Eghbali, et al.
Published: (2023-01-01)

Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome
by: Popović Irena, et al.
Published: (2015-01-01)

Efficacy of olanzapine in symptom relief and quality of life in gastric cancer patients receiving chemotherapy
by: Novin Nikbakhsh, et al.
Published: (2016-01-01)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021-01-01)

Olanzapine and its use for methamphetamine-induced psychosis
by: S. Nazir, et al.
Published: (2022-06-01)

Case of Secondary Tics Associated With Olanzapine in an Adult
by: Eric W. Mills, et al.
Published: (2017-08-01)

Olanzapine discontinuation emergent recurrence in bipolar disorder
by: Manu Arora, et al.
Published: (2014-01-01)

Acute Generalized Exanthematous Pustulosis Induced by Olanzapine
by: Susanne Christen, et al.
Published: (2006-01-01)